Automated Check-in Data Collection Study (ACDC)

The aim of this study is to examine patient acceptability, for providing brief research information, whilst self-completing an automated check-in screen prior to any general practice consultation.

Study Overview

• Status: Completed
• Conditions: Primary Care

Detailed Description

The Automated Check-in Data Collection (AC DC) Study, is a pilot feasibility study, observing patients consulting in general practice and completing an automated check-in screen prior to their booked appointment, to confirm their attendance. Participants will be recruited over three weeks from approximately 11 participating general practices.

The primary objective of the study is to assess patient acceptability for answering brief research questions in the general practice waiting room, using an automated check-in screen. This will be measured by observing the percentage of completed automated check-in screens with entered research data.

Secondary objectives will assess check-in completion of self-reported pain and willingness to be contacted about future research studies of relevance. Reported severity of bodily pain experienced over the last 4 weeks and the proportion of patients agreeing to be contacted about future research studies of relevance, will be observed.

• Study Type: Observational
• Enrollment (Actual): 9274

Contacts and Locations

Study Locations

• United Kingdom
  • Wolverhampton, United Kingdom, WV10 0QP
    • New Cross Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

All patients of age 18 and over, who can read and respond in English and with a booked appointment, consulting with any Health Care Professional (HCP) at their general practice, during the recruitment period will be eligible to participate. All patients are required to confirm their attendance at the general practice by using the automated check-in screen. If the patient completing the automated check-in screen is 18 years of age or over, the additional two research questions will appear for completion.

Description

Inclusion Criteria:

• Patients 18 years of age or over attending participating general practices for a consultation with any healthcare professional.
• Patients registered with the participating general practice during the specified recruitment period.
• Patients able to read and respond in English.

Exclusion Criteria:

• Patients under the age of 18 attending the general practice for a consultation with a healthcare professional.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Self-reported Bodily Pain	To assess what self-reported degrees of pain were reported by participants and what proportion of participants did answer a research question within the general practice waiting room using an automated check-in screen.	Through study completion at 1st visit (Day 1)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Bodily Pain Response	Proportion of participants answering the bodily pain research question using an automated check-in screen.	Through study completion at 1st visit (Day 1)
Consent to Contact Response	Proportion of participants answering the consent to contact research question using an automated check-in screen.	Through study completion at 1st visit (Day 1)

Collaborators and Investigators

• Sponsor: Keele University
• Investigators: Study Director: Christian D Mallen, University of Keele

Study record dates

Study Major Dates

• Study Start (Actual): January 14, 2019
• Primary Completion (Actual): April 14, 2019
• Study Completion (Actual): April 14, 2019

Study Registration Dates

• First Submitted: September 14, 2018
• First Submitted That Met QC Criteria: January 8, 2019
• First Posted (Actual): January 10, 2019

Study Record Updates

• Last Update Posted (Actual): April 19, 2021
• Last Update Submitted That Met QC Criteria: March 23, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: RG-0275-18 V1.0

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No